Our studies on our most advanced smoke-free alternative product, the Tobacco Heating System (THS),1 are progressing rapidly. PMI’s studies support the following for the THS (when used as intended):
The studies to date indicate that the THS has the potential to present less risk of harm compared to continued smoking for adult smokers who switch to it completely.
PMI has filed a Modified Risk Tobacco Product Application (MRTPA) for the THS with the U.S. FDA, but the U.S. FDA has not yet reviewed, nor reached any conclusions about our data. The THS is not for sale in the United States.
1 Outside the United States, the THS is marketed as IQOS.
For a full description of our study results, visit PMIScience.com and read our Scientific Update.
We are committed to seeking independent verification of the scientific data we have generated on our RRPs.* There are several components to this verification:
* Reduced-risk products (RRPs) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce far lower quantities of harmful and potentially harmful compounds than found in cigarette smoke.
Heating tobacco to release flavors and nicotine while eliminating combustion.
How long will PMI be in the cigarette business?
Shouldn’t smokers be able to choose less harmful alternatives to cigarettes?